CTNM — CONTINEUM THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in CONTINEUM THERAPEUTICS INC (CTNM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.62% (2025 Q4)
Avg. % of fund
0.62%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 816,326 — — 0.62% $9.3M $11.43
% of Fund (quarterly)    CTNM price (monthly, adj. close)

Other funds also holding CTNM

As of 2025 Q4 — sorted by position size

SECTORAL ASSET MANAGEMENT INC 3Y 7Y 7.34% Versant Venture Management, LLC 3Y 7Y 4.11% JOHNSON & JOHNSON 3Y 4.08% GREAT POINT PARTNERS LLC 3Y 7Y 2.96% Monashee Investment Management LLC 3Y 7Y 0.89% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 0.67% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.49% Longaeva Partners L.P. 0.45% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.38% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.3%
← Back to Commodore Capital LP Holdings